Similar Search Results

Evaluation and Learning in R&D Investment

Frankel, Alex; Krieger, Joshua L.; Li, Danielle; … - National Bureau of Economic Research - 2023

We examine the role of spillover learning in shaping the value of exploratory versus incremental R&D. Using data from drug development, we show that novel drug candidates generate more knowledge spillovers than incremental ones. Despite being less likely to reach regulatory approval, they are...

Persistent link: https://www.econbiz.de/10014287391

COVID-19 vaccines and the role of patents

Larson, Kelli - In: International journal of intellectual property … 11 (2021) 4, pp. 486-491

Persistent link: https://www.econbiz.de/10012800211

Improving Regulation for Innovation : Evidence from China's Pharmaceutical Industry

Jia, Ruixue; Ma, Xiao; Yang, Jianan; Zhang, Yiran - National Bureau of Economic Research - 2023

This study investigates how enhanced regulation can promote innovation, focusing on the impacts of a significant … recognized the improvement in drug innovation, as reflected in stock price adjustments post new drug registrations after the … latecomers could boost their innovation potential by adopting specific, effective regulatory practices from frontier countries …

Persistent link: https://www.econbiz.de/10014447297

How does basic research improve innovation performance in the world's major pharmaceutical firms?

Leten, Bart; Kelchtermans, Stijn; Belderbos, René - In: Industry and innovation 29 (2022) 3, pp. 396-424

Persistent link: https://www.econbiz.de/10013170079

Rival signals and project selection : insights from the drug development process

Markou, Panos; Kavadias, Stylianos; Oraiopoulos, Nektarios - In: Management science : journal of the Institute for … 69 (2023) 9, pp. 5298-5315

Persistent link: https://www.econbiz.de/10014392911

Chapter 12. Pharmaceutical Innovation

Scherer, F.M. - 2010

This chapter surveys the costs, risks, and challenges encountered in the progressive discovery and development of new pharmaceuticals. The changing methods by which drugs are discovered, the links between companies and academic science, the changing character of public regulation, and the sharp...

Persistent link: https://www.econbiz.de/10014025164